Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
Petra Hirsova, Friederike Böhm, Ester Dohnálková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 24

Showing 24 citing articles:

Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1272
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 286
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Virender Kumar, Xiaofei Xin, Jingyi Ma, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113888-113888
Open Access | Times Cited: 109
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed Samy, Mohamed A. Kandeil, Dina Sabry, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30387-e30387
Open Access | Times Cited: 15
Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Petra Hirsova, Adebowale O. Bamidele, Haiguang Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 54
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, et al.
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 39
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Metabolism (2022) Vol. 134, pp. 155264-155264
Closed Access | Times Cited: 25
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1308-1308
Open Access | Times Cited: 12
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
Dániel Kucsera, Viktória É. Tóth, Nabil V. Sayour, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma
Alex José de Melo‐Silva, Juliana Ellen de Melo Gama, Sheilla Andrade de Oliveira
International Journal of Cell Biology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
Reda Albadawy, Amany Helmy Hasanin, Sara H. A. Agwa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10148-10148
Open Access | Times Cited: 16
PKC-δ-dependent mitochondrial ROS attenuation is involved as 9-OAHSA combats lipoapotosis in rat hepatocytes induced by palmitic acid and in Syrian hamsters induced by high-fat high-cholesterol high-fructose diet
Ching‐Hui Loh, Wei‐Wen Kuo, Shinn‐Zong Lin, et al.
Toxicology and Applied Pharmacology (2023) Vol. 470, pp. 116557-116557
Closed Access | Times Cited: 9
A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer
Brisa Rodope Alarcón‐Sánchez, Osiris Germán Idelfonso-García, Dafne Guerrero‐Escalera, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116209-116209
Open Access | Times Cited: 3
Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer
Kara Wegermann, Jeongeun Hyun, Anna Mae Diehl
Clinical Liver Disease (2021) Vol. 17, Iss. 1, pp. 6-10
Open Access | Times Cited: 19
The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation
Lynda Bourebaba, Sai Santosh Babu Komakula, Christine Weiß, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0278566-e0278566
Open Access | Times Cited: 7
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Santiago Iturbe-Rey, Cláudia Maccali, Marco Arrese, et al.
Atherosclerosis (2024) Vol. 400, pp. 119053-119053
Open Access | Times Cited: 2
Physiological Functions of Mcl-1: Insights From Genetic Mouse Models
Hui San Chin, Nai Yang Fu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12
Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma
Utibe-Abasi Udoh, Moumita Banerjee, Pradeep Rajan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7359-7359
Open Access | Times Cited: 7
Hydrogen Sulfide and Its Donors: Keys to Unlock the Chains of Nonalcoholic Fatty Liver Disease
Xianghui Li, Kaixin Jiang, Yantian Ruan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12202-12202
Open Access | Times Cited: 7
Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders
Alireza Motamedzadeh, Fatemeh Rahmati‐Dehkordi, Hoora Heydari, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Fatty liver progression and carcinogenesis: Beware of pathogenic T cells
Petra Hirsova, Gregory J. Gores
Med (2021) Vol. 2, Iss. 5, pp. 453-455
Open Access | Times Cited: 6
Integrative Transcriptomic Analysis Reveals Upregulated Apoptotic Signaling in Wound-Healing Pathway in Rat Liver Fibrosis Models
Jihyun Kim, Chang‐Yong Lee, Sang Gyun Noh, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1588-1588
Open Access | Times Cited: 2
Baculovirus repeat-containing ubiquitin conjugating enzyme regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis
Chrystelle L. Vilfranc, Lixiao Che, Krushna C. Patra, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 3, pp. 343-361
Open Access | Times Cited: 3
Revisión Bibliográfica Alto Consumo de Fructosa y Daño Hepático
Lina M. Ciro Ramírez, Johanna Gutiérrez‐Vargas
Revista Novedades Colombianas (2020) Vol. 15, Iss. 1, pp. 7-19
Open Access
Page 1

Scroll to top